WeVote
Log In

Bill

Bill

HD 1759

An Act to protect the independence of clinical decision making

194th Legislature (2025-2026) Introduced by Jay Livingstone

Massachusetts bill requiring insurance companies to have qualified medical professionals—not just administrators—approve or deny physician-prescribed treatments using evidence-based standards.

0
WeVote Research Nonpartisan
Bill Summary · HD 1759

Legislative bill overview

HD 1759 aims to protect physician autonomy in clinical decision-making by limiting insurance companies' and managed care organizations' ability to override or second-guess medical treatment decisions. The bill establishes requirements that any denial or modification of prescribed treatments must be based on medically accepted evidence and determined by qualified healthcare professionals, not just administrative staff or algorithms.

Why is this important

This addresses a real-world tension in healthcare where insurance companies deny or delay coverage for treatments doctors recommend, sometimes forcing patients into lengthy appeals while their conditions progress. The bill could reduce administrative barriers to care, though it also affects insurers' cost-control mechanisms and may influence premium pricing and healthcare costs.

Potential points of contention

  • Cost implications: Limiting insurers' ability to deny treatments could increase healthcare spending and insurance premiums, as insurers lose a major cost-containment tool
  • Definition of "medically accepted evidence": Disputes may arise over what counts as sufficient evidence, potentially leading to litigation over borderline treatments
  • Balance of interests: The bill prioritizes physician judgment over payers' fiscal responsibility; critics argue this ignores legitimate concerns about unnecessary or experimental treatments that drive up costs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.